Monthly information on share capital and company voting rights
Press Releases

Monthly information on share capital and company voting rights

PARIS, Sept. 04, 2024 (GLOBE NEWSWIRE) —

Listing market: Euronext Growth

ISIN code: FR0010425595

Date Total number of shares
in the capital
Total number of voting rights
08/31/2024 100,093,635 88,029,440

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:       

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com

 

Attachment

Related Articles
TipRanks Auto-Generated NewsdeskCellectis’ Breakthrough in TNBC Therapy
TheFlyCellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC
TipRanks Auto-Generated NewsdeskCellectis Reveals Promising Cancer Therapy Breakthrough
Go Ad-Free with Our App